Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis: A 4-week comparative multicenter trial

Annals of Allergy, Asthma and Immunology

Volumn 76, Issue 2, 1996, Pages 181-188

  LaForce, Craig ^a,g   Dockhorn, Robert J ^b   Prenner, Bruce M ^c   Chu, Theodore J ^d   Kraemer, Michael J ^e   Widlitz, Michael D ^f   D'Eletto, Thomas A ^f   Freitag, Jeffrey J ^f  

^a Carolina Allerg and Asthma Consult   (United States)

^b Immuno Allerg Tech Consult Inc   (United States)

^c Allergy Associates Medical Group Inc   (United States)

^d Allergy & Asthma Associates of Northern California   (United States)

^e Spokane Allergy and Asthma Clinic   (United States)

^f Church & Dwight Co   (United States)

^g Carolina Allerg and Asthma Consult   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; AZELASTINE; CHLORPHENIRAMINE MALEATE; PHTHALAZINE DERIVATIVE; PLACEBO;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG TOLERABILITY; DYSGEUSIA; EPISTAXIS; FEMALE; HEADACHE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; POLLEN ALLERGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SIDE EFFECT; SNEEZING; SOMNOLENCE; XEROSTOMIA;

EID: 0030020365     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63420-5     Document Type: Article

References (25)

1. Perhach JL, Freitag JJ, Rosenberg A. Azelastine: a review in light of current concepts and therapies. J Respir Dis 1989;10(suppl):S75-S85.
2. Perhach JL, Connell JT, Kemp JP. Treatment of upper and lower airway disease with azelastine. N Engl Reg Allergy Proc 1987;8:121-4.
3. 4 formation and histamine secretion by azalastine: implication for its mechanism of action. Int Arch Allergy Immunol 1989;90:67-70.
4. Busse W, Randley B, Sedgwick J, et al. The effect of azelastine on neutrophil and eosinophil generation of superoxide. [Abstract] J Allergy Clin Immunol 1988;81:212.
5. Umeki S. Effects of anti-allergic drugs on human neutrophil superoxide-generating NADPH oxidase. Biochem Pharmacol 1992;43:1109-17.
6. 2+ influx, actin polymerization and release of eosinophil cationic protein of an eosinophilic leukemia cell line EoL-1. Curr Med Res Opin 1993;13:163-74.
7. Tamaoki J, Chiyotani A, Sakai N, et al. Effect of azelastine on sulphur dioxides induced impairment of ciliary motility in airway epithelium. Thorax 1993;48:542-6.
8. Nieber K, Baumgarten C, Rathsack R, et al. Effect of azelastine on substance P content in bronchoalveolar and nasal lavage fluids of patients with allergic asthma. Clin Exp Allergy 1993;23: 69-71.
9. 4 release and production by bronchial asthmatic eosinophils. Respir Res 1990;9:206-12.
10. Shirasaki H, Asakura K, Sohma S, Kataura A. Inhibitory effects of azelastine on nasal allergic responses in sensitized guinea pigs. Eur Arch Otorhinolaryngol 1992;249:279-82.
11. Shin M-H, Baroody F, Proud D, et al. The effect of azelastine on the early allergic response. Clin Exp Allergy 1992;22:289-95.
12. Metzger WJ, Ali S, Mustafa SJ. Inhibition of allergen-induced airway obstruction and airway hyperresponsiveness in an allergic rabbit model by azelastine [Abstract] J Allergy Clin Immunol 1991;87:312.
13. Rafferty P, Ng WH, Phillips G, et al. The inhibitory actions of azelastine hydrochloride on the early and late bronchoconstrictor responses to inhaled allergen in atopic asthma. J Allergy Clin Immunol 1989;84:649-57.
14. Frick OL The late reaction in asthma. Allergy Immunol 1990;22:368-72.
15. Shindoh J, Sugiyama S, Takagi K, et al. Recovery time course of airway hyper-responsiveness to acetylcholine after ovalbumin challenge in guinea pigs. Chest 1991;99:1274-9.
16. 1 activity. FASEB J 1992;6:A1068.
17. Chand N, Adusumalli VE, Nolan K, et al. Pharmacodynamic and pharmacokinetic studies with azelastine in the guinea pig: evidence for preferential distribution into the lung. Allergy 1993;48:19-24.
18. Perhach JL, Chand N, Diamantis W, et al. Azelastine: a novel oral anti-asthma compound with several modes of action. In: Kay AB, ed. Allergy and asthma: new trends and approaches to therapy. Oxford: Blackwell Scientific Publications, 1989:230-48.
19. Tinkelman DG, Bucholtz GA, Kemp JP, et al. Evaluation of the safety and efficacy of multiple doses of azelastine to adult patients with bronchial asthma over time. Am Rev Respir Dis 1990; 141:569-74.
20. Meltzer EO, Storms WW, Pierson WE, et al. Efficacy of azelastine in perennial allergic rhinitis: clinical and rhinomanometric evaluation. J Allergy Clin Immunol 1988;82:447-55.
21. Weiler JM, Meltzer E, Benson PM, et al. A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model. J Allergy Clin Immunol 1994;94: 972-80.
22. Meltzer EO, Weiler JM, Dockhorn R, et al. Azelastine nasal spray in the management of seasonal allergic rhinitis. Ann Allergy 1994;72:354-9.
23. Connell JT. A novel method to assess antihistamine and decongestant efficacy. Ann Allergy 1979;42:278-84
24. Storms WW, Grossman J, Pearlman DS, et al. Effectiveness of azelastine nasal solution in seasonal allergic rhinitis. ENT Journal 1994;73:382-94.
25. Ratner PH, Findlay SR, Hampel F Jr, et al. A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis. J Allergy Clin Immunol 1994;94:818-25.